|PT Tempo Scan Pacific Tbk -- USA Stock|| |
USD 0.14 0.00 0.00%
Ms. Aviaska Diah Respati Herlambang serves as a Director of PT Tempo Scan Pacific Tbk since May 20 2011. She graduated from the Faculty of Dentistry of Universitas Gadjah Mada. She has served as Company Marketing ManagerAnalgesic Cough Cold General ManagerBrand Communication Strategy and as General ManagerBrand Communication Promotion. She promoted to Marketing DirectorOTC Self Medication in 2008 until 2010 before being promoted again to serve as Managing DirectorConsumer Health Pharma PT Tempo Scan Pacific Tbk. Prior joining the Company she worked at PT Kalbe Farma from 1992 to 1997 with her last position as Group Product Manager OTC.
Age: 49 Director Since 2011 MBA
62 21 2921 8888 http://www.thetempogroup.net
The company has return on total asset (ROA)
of 6.12 %
which means that it generated profit of $6.12 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 10.5 %
meaning that it generated $10.5 on every $100 dollars invested by stockholders.
The company has accumulated 8.01 M in total debt with debt to equity ratio (D/E) of 0.02 which may suggest the company is not taking enough advantage from borrowing. PT Tempo Scan Pacific Tbk has Current Ratio of 2.59 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
PT Tempo Scan Pacific Tbk manufactures, markets, and distributes pharmaceuticals, consumer and household products, and cosmetics in Indonesia and internationally. PT Tempo Scan Pacific Tbk (PEXXF) is traded on OTC Market in USA. It is located in Jakarta, and employs 6,000 people.